Evaluation of the efficiency of clomiphene citrate plus letrozole on intrauterine insemination outcome
Phase 3
Recruiting
- Conditions
- Female infertility.Female infertility
- Registration Number
- IRCT20180528039878N1
- Lead Sponsor
- Mehr medical institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 501
Inclusion Criteria
Age = 38 years•
Basal FSH level <10
Patients without history of allergic reactions to clomiphene
Mild male factor infertility
Unexplained infertility
Anovolatory patients who have not been pregnant despite the use of ovulation induction techniques and appropriate follicles
Exclusion Criteria
No response to ovulation induction
Patients with large number of follicles who cannot receive hCG
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: Seven weeks after intrauterine insemination. Method of measurement: Observation of gestational sac on transvaginal ultrasound.
- Secondary Outcome Measures
Name Time Method umber of follicles = 18 mm. Timepoint: On hCG administration day. Method of measurement: By transvaginal ultrasound.;Follicular size on hCG day. Timepoint: On hCG administration day. Method of measurement: By transvaginal ultrasound.;Duration of ovarian stimulation. Timepoint: At the end of ovarian stimulation. Method of measurement: Number of days.;Endometrial thickness on hCG administration day. Timepoint: On hCG administration day. Method of measurement: By transvaginal ultrasound.;Gonadotropin dosage. Timepoint: At the end of ovarian stimulation. Method of measurement: International Units.